GlassScriptPhysician profile
Edward S Yarbro
NPI 1841273190
$388.38
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $136 · 2021: $51.71.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $121.33 | 2020 | |
| Astellas Pharma US INC | $118.57 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $36.90 | 2019 | |
| Olympus America INC. | $21.29 | 2019 | |
| Tolmar Pharmaceuticals, INC. | $17.88 | 2019 | |
| Allergan, INC. | $16.96 | 2019 | |
| Coloplast Corp | $15.12 | 2021 | |
| Blue Earth Diagnostics | $14.46 | 2020 | |
| Abbvie INC. | $13.54 | 2019 | |
| Urovant Sciences INC | $12.33 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Yarbro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.